These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 25458797)

  • 1. Personalized medicine in children with asthma.
    Pijnenburg MW; Szefler S
    Paediatr Respir Rev; 2015 Mar; 16(2):101-7. PubMed ID: 25458797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of anti-inflammatory treatment in children with asthma: rationale and design of the PACMAN cohort.
    Koster ES; Raaijmakers JA; Koppelman GH; Postma DS; van der Ent CK; Koenderman L; Bracke M; Maitland-van der Zee AH
    Pharmacogenomics; 2009 Aug; 10(8):1351-61. PubMed ID: 19663678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision medicine in childhood asthma.
    Slob EM; Maitland-Van der Zee AH; Koppelman GH; Pijnenburg MW
    Curr Opin Allergy Clin Immunol; 2019 Apr; 19(2):141-147. PubMed ID: 30649013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhaled corticosteroid treatment on exhaled breath condensate leukotriene E(4) in children with mild asthma.
    Steiss JO; Rudloff S; Landmann E; Rückes-Nilges C; Zimmer KP; Lindemann H
    Allergy Asthma Proc; 2008; 29(4):371-5. PubMed ID: 18702883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers and asthma management: analysis and potential applications.
    Richards LB; Neerincx AH; van Bragt JJMH; Sterk PJ; Bel EHD; Maitland-van der Zee AH
    Curr Opin Allergy Clin Immunol; 2018 Apr; 18(2):96-108. PubMed ID: 29389730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractional Exhaled Nitric Oxide Monitoring Does Not Improve Asthma Management in Children with Concordant and Discordant Asthma Phenotypes.
    Voorend-van Bergen S; Vaessen-Verberne AA; Landstra AM; Brackel HJ; van den Berg NJ; Merkus PJ; de Jongste JC; Pijnenburg MW
    Am J Respir Crit Care Med; 2015 Oct; 192(8):1016-8. PubMed ID: 26469843
    [No Abstract]   [Full Text] [Related]  

  • 7. New approaches to personalized medicine for asthma: where are we?
    Weiss ST
    J Allergy Clin Immunol; 2012 Feb; 129(2):327-34. PubMed ID: 22284929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaled NO is a poor marker of asthma control in children with a reported use of asthma medication: a pharmacy-based study.
    Vijverberg SJ; Koster ES; Koenderman L; Arets HG; van der Ent CK; Postma DS; Koppelman GH; Raaijmakers JA; Maitland-van der Zee AH
    Pediatr Allergy Immunol; 2012 Sep; 23(6):529-36. PubMed ID: 22624949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma: personalized and precision medicine.
    Canonica GW; Ferrando M; Baiardini I; Puggioni F; Racca F; Passalacqua G; Heffler E
    Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):51-58. PubMed ID: 29189350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care.
    Honkoop PJ; Loijmans RJ; Termeer EH; Snoeck-Stroband JB; van den Hout WB; Bakker MJ; Assendelft WJ; ter Riet G; Sterk PJ; Schermer TR; Sont JK;
    J Allergy Clin Immunol; 2015 Mar; 135(3):682-8.e11. PubMed ID: 25174865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?
    De Ferrari L; Chiappori A; Bagnasco D; Riccio AM; Passalacqua G; Canonica GW
    Expert Rev Respir Med; 2016; 10(1):29-38. PubMed ID: 26566089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic basis for personalized medicine in asthma.
    Portelli M; Sayers I
    Expert Rev Respir Med; 2012 Apr; 6(2):223-36. PubMed ID: 22455494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled nitric oxide in the diagnosis and management of childhood asthma.
    Kercsmar C
    Ther Adv Respir Dis; 2010 Apr; 4(2):71-82. PubMed ID: 20215487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
    Fajt ML; Wenzel SE
    J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized Approach to Severe Asthma.
    Heffler E; Canonica GW; Diamant Z; Fonseca J; Malinovschi A
    Biomed Res Int; 2018; 2018():2465172. PubMed ID: 30671448
    [No Abstract]   [Full Text] [Related]  

  • 17. Exhaled nitric oxide and the management of childhood asthma--yet another promising biomarker "has been" or a misunderstood gem.
    Turner S
    Paediatr Respir Rev; 2015 Mar; 16(2):88-96. PubMed ID: 25182668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of sputum eosinophils and exhaled nitric oxide for monitoring asthma control with special attention to childhood asthma.
    Garcia-Marcos L; Brand PL
    Allergol Immunopathol (Madr); 2010; 38(1):41-6. PubMed ID: 20056307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
    Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
    J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Control Asthma with Personalized Management: Where Do We Stand Now?
    Wang M; Yao Y; Jiang S; Tao F; Tang R; Sun J
    Curr Drug Metab; 2018; 19(14):1188-1198. PubMed ID: 29380695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.